Upcoming Medical Conferences in San FranciscoSearch Criteria : United States of America San Francisco
Nov 15 - 16, 2019 | CME 10.00 | USD $400 | San Francisco, California
UCSF CME: Updates in Inflammatory Bowel Disease 2019 is organized by The University of California, San Francisco (UCSF) Office of Continuing Medical Education and will be held from Nov 15 - 16, 2019 at The St. Regis San Francisco, San Francisco, California, United States of America. Who should attend this course: This symposium is designed for gastroenterologists, colorectal surgeons, internists, and advanced health practitioners who participate in the management of this complicated patient population. Accreditation: The University of California,San Francisco School of Medicine (UCSF) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. UCSF designates this live activity for a maximum of 10.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. ABIM Maintenance of certification Points: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 10.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Overview: The UCSF Center for Colitis and Crohn's Disease is dedicated to providing comprehensive care for individuals with Crohn's disease, ulcerative colitis, and related illnesses. As part of this commitment, we are proud to present our sixteenth annual inflammatory bowel disease (IBD) symposium. This course will address advances in the medical and surgical management of Crohn’s disease and ulcerative colitis including novel therapies and optimizing current medications. We will also address patient safety concerns including adverse events of therapy, prevention of opportunistic infections, and substance use counseling. Objectives: Upon completion of this course, attendees will refine their approaches to: • The appropriate type and timing of therapy for the patient with moderate to severe IBD; • The role of the environment and microbiome in IBD; • Using diet as a therapy for IBD; • Diagnosing checkpoint inhibitor colitis and be able to treat it; • Managing obstructive symptoms with medical or surgical therapy; • Weighing the risks and benefits of therapies for IBD and reduce the rate of adverse events; • Counseling patients on tobacco, alcohol, and cannabis consumption.
Expert-Led Seminars on Psoriatic Diseases, Atopic Dermatitis & Rheumatoid Arthritis for practitioners in Federal & Public Health Services
Nov 16, 2019 | CME 6.00 | San Francisco, California
Expert-Led Seminars on Psoriatic Diseases, Atopic Dermatitis & Rheumatoid Arthritis for practitioners in Federal & Public Health Services is organized by Prime Education, LLC and will be held on Nov 16, 2019 at San Francisco Marriott Fisherman's Wharf, San Francisco, California, United States of America. Accreditation: In support of improving patient care, PRIME® is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. This activity was planned by and for the healthcare team, and learners will receive 6.0 Interprofessional Continuing Education (IPCE) credits for learning and change. Physician Credit Designation Statement: PRIME® designates this Live activity for a maximum of 6.0 AMA PRA Category 1 Credits. Physicians should claim only credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.0 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Physician Assistant Accreditation Statement: PRIME® has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credits for activities planned in accordance with AAPA CME Criteria. This activity is designated for 6.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. Nurse Practitioner Accreditation Statement: Nurse Practitioner LogoPRIME® is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 060815. This activity is approved for 6.0 contact hours of continuing education (which includes 1.49 hours of pharmacology). Pharmacist Accreditation Statement: This Application-based activity has been approved for 6.0 contact hours (0.6 CEUs) by PRIME® for pharmacists. The Universal Activity Number for this activity is JA0007144-0000-19-060-L01-P. Pharmacy CE credits can be electronically submitted to the NABP upon successful completion of the activity. Pharmacists with questions can contact NABP customer service (email@example.com). Nurse Accreditation Statement: PRIME® designates this activity for 6.0 contact hours. Learning Objectives: • Identify major barriers to evidence-based treatment and management in federal and public sectors • Implement appropriate methods for diagnosis and assessment of disease activity • Assess current evidence on targeted biologic and small-molecule therapies to guide treatment decisions for patients with moderate to severe disease • Monitor treatment responses according to treat-to-target principles and methods • Apply current evidence and guidelines to inform treatment decisions for patients with inadequate responses to initial therapies • Incorporate patient-reported outcomes and shared decision-making into clinical practice • Apply effective strategies for multidisciplinary care coordination and shared patient management
Nov 16 - 17, 2019 | CME/CE 22.00 | USD $1,875 | San Francisco, California
PBI Medical Ethics & Professionalism (ME-22) is organized by Professional Boundaries Education and will be held from Nov 16 - 17, 2019 at Hilton San Francisco Airport Bayfront, San Francisco, California, United States of America. Professions this course is suitable for: Physicians, dentists, veterinarians, chiropractors, physician assistants, nurses, mental health providers, EMT's, physical therapists, students, and a wide variety of other clinicians. Course Credit: 22 CME/CE hours This course addresses issues such as: • Misrepresentation, falsification, cheating • Financial improprieties • Breaking laws • HIPAA or confidentiality violations • Practicing on an expired license Learning objectives: • Comply with standards of practice, codes of ethics, and state statutes • Improve clinical decision making by minimizing negative influencers • Adhere to professional ethics with resultant improvements in professional-patient interaction, which can improve clinical outcomes • Reduce their potential transgressions through the development of systems that can be implemented into clinical practice • Become aware of the early warning signs indicative of ethical dilemmas and boundary problems • Create and implement a tiered Protection Plan to maintain appropriate boundaries
Nov 16 - 17, 2019 | Contact H 15.00 | USD $495 | San Francisco, California
Proprioceptive Neuromuscular Facilitation in Orthopedic Patients is organized by Therapy Network Seminars (TNS) and will be held from Nov 16 - 17, 2019 at Saint Francis Memorial Hospital, San Francisco, California, United States of America. Target Audience: This course is intended for PTs, PTAs, OTs, OTAs and ATs Educational Credit: A certificate of attendance for 15 Contact Hourswill be awarded to each participant. All Therapy Network Seminars are pre‐approved for CEUs in the state where the course is conducted when required for PT, OT, ATC & Assistants. BOC Board of Certification, Inc. Approved Provider Course Description: This two-day, evidenced based, laboratory intensive course will focus on teaching a historically useful manual therapy technique, Proprioceptive Neuromuscular Facilitation (PNF). The course introduces PNF as a manual therapy and exercise intervention technique to address common pathologies of both upper and lower extremities. The course is intended to provide the clinician with the skill to rehabilitate the patient with a hands-on, integrative approach. This will be accomplished through a combination of lecture, demonstration, and significant lab time. The structured sessions are aimed at emphasizing important concepts in neurophysiology and motor learning to improve neuromuscular control in orthopedic patients. Mastery of these techniques requires a solid foundation in basic anatomy and the pathomechanics of the shoulder and hip. Attendees will learn useful terminology, basic procedures, and techniques. Participants will learn to successfully apply PNF techniques in a manner that each patient-centered session is both therapeutic intervention and assessment or evaluation. The clinician will learn to develop and sequence a dynamic treatment plan incorporating PNF techniques that can be used for conservative and post-operative approaches. Current clinical evidence supports the combination of these treatments when properly performed and prescribed by a skilled clinician. Strategies for documentation and coding will also be covered. Objectives: • Develop an understanding of the PNF concept and the neurophysiology behind the PNF principles • Understand foundational principles of exercise and physiological adaptation. Correctly explain and differentiate motor learning, strength, power, hypertrophy, and endurance • Demonstrate clinical skills to determine a patient’s neuromuscular ability and select appropriate PNF therapy interventions based on understanding of anatomy and pathology in conjunction with patient responses • Perform basic PNF manual therapy techniques to facilitate neuromuscular control and improve patient recovery • Articulate appropriate PNF terms for documentation and CPT coding for charges.
Dec 03 - 07, 2019 | San Francisco, California
California Society of Pathologists (CSP) 72nd Annual Meeting is organized by California Society of Pathologists (CSP) and would be held during Dec 3 - 7, 2019 at Hyatt Regency San Francisco, San Francisco, California, United States Of America. Additional details will be posted as soon as they are available.
Dec 03 - 05, 2019 | Hours 22.50 | USD $1,995 | San Francisco, California
Comprehensive Monitoring for Medical Devices Course is organized by Barnett International and will be held from Dec 03 - 05, 2019 at Hilton San Francisco Union Square, San Francisco, California, United States of America. Who Should Attend: CRAs with one to two years of experience, and Engineers and other Device Industry Professionals responsible for the placement and monitoring of clinical trials, who want a practical, hands-on introduction to monitoring medical device studies according to Good Clinical Practice Accreditation Information: Barnett International is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Participants will receive 22.5 hours (2.25 CEUs) of continuing education credit for full participation. Description: This course provides an in-depth overview of the medical device development process and the role of the Clinical Research Associate (CRA) in managing and monitoring medical device studies. This course is ideal for CRAs new to the device industry, as well as experienced CRAs who are transitioning from monitoring drug studies to monitoring device studies. Learning Objectives: • Discuss the FDA regulations pertaining to clinical research and describe the ICH structure and function • Define the common terms used in the field of device clinical research and identify the three ways devices are characterized • Prepare and conduct a pre-investigation visit, an investigator’s meeting, an initiation visit, a periodic visit, and a closeout visit • List the types of regulatory and study documents required for the sponsor and for the investigator • List both the sponsor’s and investigator’s obligations as they relate to device accountability • Describe the differences between adverse events, adverse device effects, and unanticipated adverse device effects • Discuss the “dos and don’ts” in the event of an FDA inspections
Dec 03 - 05, 2019 | USD $3,095 | San Francisco, California
World Vaccine & Immunotherapy Congress West Coast 2019 is organized by Terrapinn Ltd and will be held from Dec 03 - 05, 2019 at San Francisco Airport Marriott Waterfront, San Francisco, California, United States of America. The World Vaccine & Immunotherapy Congress is moving to San Fransisco in 2019 to bring you even more content, learning and business development opportunities so you can take advantage of the rich biotech and funding environment that the West Coast offers. Whilst still focussing on the vaccine and immunotherapy industry the scope of the event has expanded considerably and will delve deeper into topics surrounding vaccine development, cancer immunotherapy, funding and partnerships as well as exploring new topics in clinical trials & development, bioprocessing, manufacture and delivery, and the development and use of antibodies for both infectious diseases and cancer. This is the congress for top decision makers of the vaccine and immunotherapy industry with both scientific and commercial interests, specifically interested in both learning and/or partnering. No matter where your interest lies we have content, networking and potential partners for you. Additional details will be posted as soon as they are available.
2-Day Psychopharmacology Conference for Today’s Mental Health Professional: "Must Have" Information to Better Serve Your Clients - San Francisco
Dec 05 - 06, 2019 | Contact Hours 12.60 | USD $500 | San Francisco, California
2-Day Psychopharmacology Conference for Today’s Mental Health Professional: "Must Have" Information to Better Serve Your Clients is organized by PESI HealthCare and will be held from Dec 05 - 06, 2019 at Holiday Inn San Francisco-Golden Gateway, San Francisco, California, United States of America. This Conference has been approved for a maximum of 12.5 Clock hours / 12.6 Contact hours / 12.5 AMA PRA Category 1 Credit(s)™. Target Audience: • Counselors • Nurses • Nurse Practitioners • Clinical Nurse Specialists • Physician Assistants • Psychotherapists • Psychologists • Social Workers • Case Managers • Marriage and Family Therapists • Addiction Counselors • Pharmacists • Occupational Therapists • Occupational Therapist Assistants • School Psychologists • Others in caring professions Description: Spend two action-packed days learning about the newest advances in psychopharmacology and contemporary trends in medication management. From her unique perspective, Sharon Freeman Clevenger, MSN, MA, PMHCNS-BC, CARN-AP teaches psychopharmacology thoughtfully, with an emphasis on the experience of the client. Sharon’s years of experience in mental health and passion for clients shines through in the detail and thoroughness of her presentation. Clients often only have a few minutes with their prescriber and require additional support. It’s vital that you are able to answer their questions, help manage side effects and understand reactions. Designed for counselors, nurses, psychotherapists, psychologists, and other mental health professionals, Sharon provides the information you need in order to best help your clients. This conference allows time for exploration of underrepresented areas, including ADHD, sleep, eating, and substance use disorders. Take home specialized guidelines for geriatrics, pregnant or nursing women, and clients with chronic pain. Discuss how the DSM-5® has impacted prescribing patterns and the use of psychotropics in newly defined diagnoses. In addition to a general ‘nuts and bolts’ review of medications, you will examine case examples, discuss medication controversies and how to effectively collaborate with prescribing practitioners. Sharon’s engaging presentation includes many take home “pearls” you can use to teach your clients about their medications and how to protect them from concerning, dangerous or adverse effects. As a bonus, Sharon will discuss alternative approaches using nutrition, supplements, vitamins and essential oils. Increase your understanding about complementary alternative medications such as supplements and essential oils including expected effects, side effects and interaction effects with prescribed medications. You will find this conference to have the most up to date medication information and how to use it most effectively with your client. Objectives: DAY 1 • Specify how psychotropic medications are chosen for mood disorders and specific patient characteristics. • Analyze the actions, therapeutic uses, and side effects of antidepressants. • Assist clients in overcoming barriers that impede the efficacy of their medication regime. • Determine options for clients with treatment resistant mood disorders. • Communicate the actions, side effects, and therapeutic uses of antipsychotic medications. • Evaluate the three critical strategies for improving collaboration with prescribing practitioners. DAY 2 • Explore psychotropic medication treatment options for clients with Attention Deficit/Hyperactivity Disorder. • Articulate the efficacy of psychotropic medications in treating eating disorders and discuss how to integrate psychotherapy with psychopharmacology for successful treatment outcomes. • Formulate medication treatment options for substance use disorders and discuss how to effectively incorporate medication assisted treatments into an overall plan for care. • Analyze the interaction between women’s hormone levels and their mental health symptoms. • Explore the use of complementary and alternative agents for treatment of mental illnesses. • Determine the unique medication treatment considerations for geriatric clients.
Dec 05 - 06, 2019 | San Francisco, California
UCSF CME: Controversies in Women's Health 2019 is organized by The University of California, San Francisco (UCSF) Office of Continuing Medical Education and will be held from Dec 05 - 06, 2019 at Hotel Nikko San Francisco, San Francisco, California, United States of America. Additional details will be posted as soon as information is available.
Dec 06, 2019 | USD $270 | San Francisco, California
2019 San Francisco Regional Conference is organized by Health Care Compliance Association (HCCA) and will be held on Dec 06, 2019 at San Francisco, California, United States of America. Who should attend : • Compliance officers • In house and outside general counsel • Privacy and security officers • Regulatory affairs • VPs and directors • Government agency staff Course Description : Our one-day Regional Compliance Conferences provide attendees with a forum to interact with local compliance professionals, share information about your compliance successes and challenges, and create educational opportunities for compliance professionals to strengthen the industry. Regional Conferences offer professionals convenient, local compliance training, updates on the latest news in regulatory requirement, compliance enforcement, and strategies to develop effective compliance programs. Attendees also enjoy networking with industry peers. Additional details will be posted as soon as they are available.